XNYS · Healthcare · Drug Manufacturers - Specialty & Generic
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | Q4 2026 | 1.40 | 1.23 | -12.14% | $281.6M | ❌ Miss | -8.15% | -8.92% | — |
| 2026-05-07 | Q1 2026 | 0.85 | 0.83 | -2.35% | $2.05B | ❌ Miss | -3.68% | -15.86% | — |
| 2026-03-19 |
| Q4 2025 |
| 1.35 |
| 1.29 |
| -4.44% |
| $1.90B |
| ❌ Miss |
| +0.08% |
| +0.53% |
| -3.21% |
| 2026-02-05 | Q3 2026 | 1.16 | 1.14 | -1.72% | $283.4M | ❌ Miss | -4.39% | +2.15% | +2.50% |
| 2025-11-06 | Q2 2026 | 0.98 | 1.07 | +9.18% | $274.1M | ✅ Beat | — | — | — |
| 2025-02-06 | Q3 2025 | 1.16 | 1.22 | +5.17% | $290.3M | ✅ Beat | -0.40% | -1.91% | -0.56% |
| 2024-11-07 | Q2 2025 | 1.08 | 1.09 | +0.93% | $283.8M | ✅ Beat | +0.35% | +3.37% | +3.98% |
| 2024-08-08 | Q1 2025 | 0.86 | 0.90 | +4.65% | $267.1M | ✅ Beat | -0.88% | +2.77% | +8.66% |
Showing last 8 quarters.